BTAI

BioXcel Therapeutics Stock Price

25.54
-0.54 (-2.07%)
Upgrade to Real-Time
Regular Market
25.54

Low
23.7899

52 Week Range

High
67.74

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
BioXcel Therapeutics Inc BTAI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.54 -2.07% 25.54 13:58:59
Open Price Low Price High Price Close Price Prev Close
25.51 25.40 26.40 26.08
Bid Price Ask Price Spread News
25.50 25.55 0.05 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,465 84,680 $ 25.84 $ 2,188,314 - 23.7899 - 67.74
Last Trade Time Type Quantity Stock Price Currency
13:58:59 3 $ 25.53 USD

Period:

Draw Mode:

BioXcel Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 709.68M 27.79M 18.30M $ - $ - -3.77 -6.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.84M 0.80%

more financials information »

BioXcel Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BTAI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week25.9427.170223.789925.34372,157-0.40-1.54%
1 Month28.6428.98523.789926.63386,757-3.10-10.82%
3 Months31.0338.999423.789930.68404,255-5.49-17.69%
6 Months48.7367.7423.789939.39451,328-23.19-47.59%
1 Year47.1267.7423.789943.37495,806-21.58-45.8%
3 Years9.5874.892.4136.61317,70115.96166.6%
5 Years11.0274.892.4135.86289,46514.52131.76%

BioXcel Therapeutics Description

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701.


Your Recent History
NASDAQ
BTAI
BioXcel Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.